BioGenCell has welcomed aboard Mr. Marc Dechamps to its BioGenCell EU team, who will spearhead the activities in Europe. Formerly, Mr. Dechamps was the Executive Director of Specialty Care & Vaccines department at GSK, and subsequently, Head of the European Mid-Size Countries Region at ViiV Healthcare, a spinout company created by GSK and Pfizer.

Comments are closed.